2019 Rocky Mountain Life Science Investor and Partnering Conference Announces Presenting Companies

September conference led by Colorado BioScience Association to provide companies from across the region new opportunities for capital access

DENVER--()--Colorado BioScience Association (CBSA) today announced more than two dozen companies chosen by a panel of investors to present at the 2019 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC). Leading life science innovators from the Rocky Mountain region will pitch to investors and strategic partners during the event, to be held on September 4 and 5 in Vail, Colorado.

The 7th Biennial Rocky Mountain Life Science Investor and Partnering Conference brings together leading investors, senior executives, and top life science innovators to cultivate partnerships in the dynamic Rocky Mountain region and discuss the future of health innovation. It allows investors to evaluate fresh opportunities and offers networking opportunities for attendees in a collaborative, informal environment.

The companies chosen to pitch to a select group of corporate leaders, strategic partners and investors from major U.S. financial hubs include early and mid-stage companies doing groundbreaking work to save and improve lives in medical device, diagnostic, biotech, pharma and digital health.

Jennifer Jones Paton, President & CEO of CBSA, says:

“Supporting access to capital for companies at all stages of commercialization is a top priority for CBSA and the reason we lead the Rocky Mountain Life Science Investor and Partnering Conference. We’re pleased to introduce a dynamic group of companies representing the future of life-saving health innovation to investors from major financial hubs.”

2019 Rocky Mountain Life Science Investor & Partnering Conference Companies

     
ARIZONA    
     
Tucson     MVT – Microvascular Therapeutics

Aqualung Therapeutics (Biotechnology)

    (Biotechnology)
     
COLORADO    
    Denver
Boulder     Agathos (Digital Health)
Accure (Medical Device)     ClinOne, Inc. (Digital Health)
Aktivax (Pharmaceutical)     Health Sqyre (Digital Health)
Aspero Medical (Medical Device)     IMIDEX (Medical Device)
Biodesix (Diagnostic)     ImmunoMolecular Therapeutics

Brava Diagnostics (Diagnostic)

    (Biotechnology)
MFB Fertility (Diagnostic)    
OnKure Therapeutics (Pharmaceutical)     Highlands Ranch
Orbit Genomics (Diagnostic)     Securisyn Medical (Medical Device)
Sinfonia Biotherapeutics (Pharmaceutical)    
Solo-Dex (Medical Device)     Lafayette
   

Neuraptive Therapeutics (Biotechnology)

Westminster    
Health Scholars (Digital Health)    

Louisville

   

AmideBio (Pharmaceutical)

Fort Collins    
PhotonPharma (Biotechnology)    

Longmont

   

KromaTiD (Diagnostic)

MONTANA    
     
Bozeman    

Montana Molecular (Biotechnology)

   
     
UTAH    
     
Salt Lake City    

DiscGenics (Biotechnology)

   

Presenting companies and investors will hear from Johnson & Johnson’s Global Strategy and Digital Innovation Leader Dr. Emmanuel Fombu on the convergence of digital technologies and healthcare during a breakfast keynote, and will learn about the emergence of health systems investment to Accelerate Innovation with panelists Dr. Garrett Vygantas of OSF Ventures, Dan Galles of Providence Ventures and Kimberly Muller of CU Healthcare Innovation during a lunchtime panel discussion.

The 2019 Rocky Mountain Life Science Investor & Partnering Conference, led by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah, will kick off with a cocktail networking reception at the Vail Marriott Mountain Resort on September 4, followed by the full-day conference with company presentations on September 5.

Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn.

Event hashtag: #RockyMtnBioInvest

About the Colorado BioScience Association

Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.

Contacts

Sheliah Reynolds
Primavera Group for Colorado BioScience Association
(720) 289-4739
sheliah@theprimaveragroup.com

Release Summary

September investor conference led by Colorado BioScience Association to provide companies region new opportunities for capital access.

Contacts

Sheliah Reynolds
Primavera Group for Colorado BioScience Association
(720) 289-4739
sheliah@theprimaveragroup.com